Zomedica Corp.
ZOMDF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001684144
No open-market purchases or sales by Zomedica Corp. insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $9.50K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Zomedica Corp. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Zomedica Corp., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Blair Anthony K | COO | 1,000,000 | Aug 7, 2026 | 1 |
| DeHaan-Fullerton Karen | General Counsel | 104,300 | Aug 7, 2026 | 1 |
| Klass Russell Kevin | Sr Vice President, Sales | 104,000Indirect | Aug 7, 2026 | 7 |
| Powers Johnny D | Director | 4,425,000 | May 21, 2026 | 4 |
| Heaton Larry C II | CEO | 1,250,000 | May 8, 2026 | 1 |
| Whelan Sean | Director | – | Nov 18, 2025 | 1 |
| Rowe Jeffrey M | Director | 2,378,485Indirect | Nov 18, 2025 | 1 |
| Williams Rodney James | Director | 261,900 | Nov 18, 2025 | 1 |
| Macleod Christopher Ross | Director | 143,000 | Nov 18, 2025 | 1 |
| Cohen Robert | Director | – | Nov 18, 2025 | 1 |
| Nichols Pamela | Director | – | Nov 18, 2025 | 1 |
| Jordan Scott | Chief Financial Officer | 300,000 | Mar 19, 2025 | 0 |
| Donato Peter | Chief Financial Officer | 25,000 | Jun 11, 2024 | 0 |
| Lock Adrian | VP and General Manager | – | Mar 1, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 26, 2026 (view filing)7:41 AM ET | May 21 | 5 days | Klass Russell KevinSr. Vice President, Sales | PPurchaseCommon Stock, without par value | +104.0K | $0.103 | +$10.7K | New position104.0K after |